Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Journal of Cardiovascular Electrophysiology|September 1, 1995
A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmiasD S Echt, J T Lee, K T Murray, et al.
European Journal of Human Genetics : EJHG|December 7, 2007
Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activityP Yang, T T Koopmann, A Pfeufer, et al.
The American Journal of Cardiology|February 15, 1989
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)H L Greene, D W Richardson, A P Hallstrom, et al.
Clinical Pharmacology and Therapeutics|November 21, 2013
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testingS L Van Driest, Y Shi, E A Bowton, et al.
The Journal of Clinical Investigation|February 1, 1984
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervalsE L Carey, H J Duff, D M Roden, et al.
Clinical Pharmacology and Therapeutics|July 1, 1986
Encainide disposition in patients with renal failureR H Bergstrand, T Wang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|September 1, 1989
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmiasR F Davies, M D Lineberry, C Funck-Brentano, et al.
The New England Journal of Medicine|June 21, 1990
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenoneJ T Lee, H K Kroemer, D J Silberstein, et al.
Annals of Surgery|June 1, 1986
Indications for different modes of surgical therapy in medically refractory ventricular arrhythmiasJ W Hammon, D S Echt, W H Merrill, et al.
Clinical Pharmacology and Therapeutics|July 1, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapyS A Scott, K Sangkuhl, E E Gardner, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Journal of Cardiovascular Electrophysiology|September 1, 1995
A randomized, double-blind, placebo-controlled, dose-ranging study of dofetilide in patients with inducible sustained ventricular tachyarrhythmiasD S Echt, J T Lee, K T Murray, et al.
European Journal of Human Genetics : EJHG|December 7, 2007
Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activityP Yang, T T Koopmann, A Pfeufer, et al.
The American Journal of Cardiology|February 15, 1989
Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)H L Greene, D W Richardson, A P Hallstrom, et al.
Clinical Pharmacology and Therapeutics|November 21, 2013
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testingS L Van Driest, Y Shi, E A Bowton, et al.
The Journal of Clinical Investigation|February 1, 1984
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervalsE L Carey, H J Duff, D M Roden, et al.
Clinical Pharmacology and Therapeutics|July 1, 1986
Encainide disposition in patients with renal failureR H Bergstrand, T Wang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|September 1, 1989
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmiasR F Davies, M D Lineberry, C Funck-Brentano, et al.
The New England Journal of Medicine|June 21, 1990
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenoneJ T Lee, H K Kroemer, D J Silberstein, et al.
Annals of Surgery|June 1, 1986
Indications for different modes of surgical therapy in medically refractory ventricular arrhythmiasJ W Hammon, D S Echt, W H Merrill, et al.
Clinical Pharmacology and Therapeutics|July 1, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapyS A Scott, K Sangkuhl, E E Gardner, et al.
Pageof 24